NanoViricides is trading 5.28% down now at $1.43 on October 22, 2026, with no confirmed company-specific catalyst identified.
- A recent prospectus filing for a $2.375 million common-stock offering was reported; its connection to the decline is unestablished.
- The drop is occurring amid broader risk-off sentiment, with oil rising after reports of tanker incidents near the Strait of Hormuz and markets retreating. Macro pressure may be contributing, but does not establish the cause of NanoViricides’ move.